A new definition of multimodality treatment

Rudolf M. Huber (München, Germany)

Source: International Congress 2016 – Oligometastasis: postmodern multimodality concepts

Session: Oligometastasis: postmodern multimodality concepts
Session type: Symposium
Number: 3475

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Rudolf M. Huber (München, Germany). A new definition of multimodality treatment. International Congress 2016 – Oligometastasis: postmodern multimodality concepts

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

From staging to therapy: implications of the new staging system with a focus on multi-modal treatment options Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy Year: 2017
Regional chemotherapy: a new combined modality approach Source: Annual Congress 2004 - Lung metastases Year: 2004
Modern staging in lung cancer: from the current multidisciplinary process to novel approaches Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019
COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020
The concept of control in COPD: a new proposal for optimising therapy Source: Eur Respir J 2014; 44: 1072-1075 Year: 2014
New treatment concepts in stage IV NSCLC: personalized multidisciplinary approaches Source: Virtual Congress 2021 – Hot topics in thoracic oncology Year: 2021
Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018
Surgery as the best option in the multimodal treatment Source: Annual Congress 2013 –The management of N2 disease in non-small cell lung cancer Year: 2013
Multimodal therapeutic approach for locally advanced NSCLC in everyday practice Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
HAP/VAP : new guidelines, new approaches Source: International Congress 2018 – Chinese Programme 2018: Part II Year: 2018
Achieving consensus regarding the current treatment options for CPA Source: International Congress 2018 – Chronic pulmonary aspergillosis: from guidelines to real-life implementation Year: 2018